Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

A Multicenter, Open-Label, Phase 3 Trial to Compare the Efficacy and Safety of Lenvatinib (E7080) Versus Sorafenib in First-line Treatment of Participants With Unresectable Hepatocellular Carcinoma

Eisai Limited · 2013
ClinicalTrials.gov · Datasets · License: Public Domain · 2013
Open Source ↗
cancerhepatocellular-carcinomaneoplasms
hepatocellular carcinoma (hcc), hepatocellular carcinoma, neoplasms, cancer, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 863899
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.